Sign In
Buy MYOV
$26.98
+0 (+0%)
At Close: Jun 08, 2023
Myovant Sciences and Pfizer Provide Update on Supplemental New Drug Application for MYFEMBREE® for the Management of Moderate to Severe Pain Associated with Endometriosis
04:00am, Tuesday, 12'th Apr 2022 GlobeNewswire Inc.
BASEL, Switzerland and NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Pfizer (NYSE: PFE) announced today an update on the Supplemental New Drug Application (sNDA) for
Myovant: Approved Drugs And Upcoming Catalysts Make This A Great Long-Term Play
04:14am, Saturday, 26'th Mar 2022
Myovant: Approved Drugs And Upcoming Catalysts Make This A Great Long-Term Play
Myovant secures European recommendation for prostate cancer therapy
03:05pm, Friday, 25'th Feb 2022 Seeking Alpha
Commercial-stage pharma company, Myovant Sciences <> announced Friday that an expert panel of the European Medicines Agency ((EMA)) issued a positive opinion on Orgovyx for…
Myovant Sciences Receives Positive CHMP Opinion for ORGOVYX® (relugolix) for the Treatment of Advanced Prostate Cancer
02:00pm, Friday, 25'th Feb 2022 GlobeNewswire Inc.
BASEL, Switzerland, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced that the Committee for Med
Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q3 2021 Results - Earnings Call Transcript
08:18pm, Wednesday, 26'th Jan 2022 Seeking Alpha
Myovant Sciences Ltd. (MYOV) Q3 2021 Earnings Call Transcript
07:00pm, Wednesday, 26'th Jan 2022 The Motley Fool
MYOV earnings call for the period ending December 31, 2021.
Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q3 2021 Results - Earnings Call Transcript
03:18pm, Wednesday, 26'th Jan 2022
Myovant Sciences Ltd. (MYOV) CEO Dave Marek on Q3 2021 Results - Earnings Call Transcript
Myovant Sciences (MYOV) Reports Q3 Loss, Misses Revenue Estimates
01:15pm, Wednesday, 26'th Jan 2022 Zacks Investment Research
Myovant Sciences (MYOV) delivered earnings and revenue surprises of -15.25% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Myovant Sciences GAAP EPS of -$0.68 misses by $0.07, revenue of $54.4M in-line (NYSE:MYOV)
11:56am, Wednesday, 26'th Jan 2022 Seeking Alpha
Myovant Sciences press release (NYSE:MYOV): Q3 GAAP EPS of -$0.68 misses by $0.07.Revenue of $54.4M (+3842.0% Y/Y) in-line.
Myovant Sciences Announces Financial Results for Third Quarter of Fiscal Year 2021 and Corporate Updates
11:55am, Wednesday, 26'th Jan 2022 GlobeNewswire Inc.
BASEL, Switzerland, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced financial results for the
Myovant Sciences (MYOV) Reports Q3 Loss, Misses Revenue Estimates
09:59am, Wednesday, 26'th Jan 2022
Myovant Sciences (MYOV) delivered earnings and revenue surprises of -15.25% and 0.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Myovant Sciences Q3 2021 Earnings Preview
04:32pm, Tuesday, 25'th Jan 2022 Seeking Alpha
Myovant Sciences (NYSE:MYOV) is scheduled to announce Q3 earnings results on Wednesday, January 26th, before market open.The consensus EPS Estimate is -$0.61 and the consensus
6 Top Biotech Ideas For 2022
09:28am, Thursday, 20'th Jan 2022
6 Top Biotech Ideas For 2022
Myovant Sciences to Host Third Fiscal Quarter 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on January 26, 2022
01:30pm, Wednesday, 12'th Jan 2022 GlobeNewswire Inc.
BASEL, Switzerland, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced it will host a webcast an
Myovant Sciences to Host Third Fiscal Quarter 2021 Earnings Conference Call at 8:30 a.m. Eastern Time on January 26, 2022
08:30am, Wednesday, 12'th Jan 2022
BASEL, Switzerland, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced it will host a webcast and
